A Phase 2, Multi-Center, Randomized, Double-Blind (Part 1 and Part 3), Open-Label (Part 2), Age De Escalation, Sequential Ascending-Dose Study to Evaluate the Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine (KD-382) in Healthy Adults and Healthy Children

Authors
Category Primary study
Registry of TrialsThai Clinical Trials Registry
Year 2024
This article has no abstract
Epistemonikos ID: 5cedd8caafa0202d07dcf13c182ee3ed95756be6
First added on: Apr 11, 2025